In order to better promote the concept of tumor immunotherapy, promote the standardized treatment of clinicians, and improve the level of tumor immunotherapy, Chengdu High-tech Medical Association held two 2021 Vital Path Anti-Cancer Series Academic Conferences in July and December respectively.

The first academic conference was successfully held in Urumqi, Xinjiang on July 9. The conference focused on the interpretation of relevant policies on tumor immunity in 2021 and case sharing of related cases, creating a strong academic atmosphere for the participants. About 60 experts and scholars from inside and outside the province participated in this conference.

The second academic conference was successfully held in Chongqing on December 11. The conference invited more than 50 well-known experts and their teams in the field of esophageal cancer across the country.

The two anti-cancer academic conferences promoted inter-provincial exchanges between the oncology community, and through the exchanges, they have integrated high-quality medical resources, built a bridge of communication, and laid a solid foundation for strengthening the discipline construction of the oncology community in our province.